Cargando…

OR03-5 Fractures during Bisphosphonate Therapy after Orthotopic Liver Transplantation: Incidence and Predictors

Introduction: Bone loss is significant within the first 3 to 6 months after orthotopic liver transplantation (OLT) and is associated with high rates of fractures. Incident fractures after OLT are correlated with substantial decreased quality of life. To attempt preventing post-transplant fractures,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bégin, Marie-Josée, Ste-Marie, Louis-Georges, Geneviève, Huard, Chartrand, Raymonde, Marc, Dorais, Rakel, Agnes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Bone and Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555019/ http://dx.doi.org/10.1210/js.2019-OR03-5

Ejemplares similares

OR03-4 Atypical Femur Fracture Incidence Increases with Duration of Bisphosphonate Exposure
por: Lo, Joan, et al.
Publicado: (2019)

SAT-540 Bisphosphonates and Fracture Incidence in Young Adults
por: Choudhary, Manita, et al.
Publicado: (2019)

ODP124 Sickle Cell Bone Disease and Response to Intravenous Bisphosphonates in Children
por: Todd Alexander, R, et al.
Publicado: (2022)

SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019)

MON-LB67 Bisphosphonate Related Ocular Inflammation
por: Seetharaman, Kavita
Publicado: (2020)

PSAT188 Keeping An Eye On Bisphosphonates: Drug Induced Uveitis
por: Ataallah, Basma, et al.
Publicado: (2022)

OR03-1 The Effect of Abaloparatide on Bone Mineral Density and Fracture Incidence in Postmenopausal Women with Osteoporosis and Osteoarthritis
por: Lane, Nancy, et al.
Publicado: (2019)

SAT-532 Bisphosphonates Prevent Bone Loss Associated with Denosumab Treatment Discontinuation
por: Zanchetta, Maria Belen, et al.
Publicado: (2019)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

MON-510 Progression of Atypical Femur Stress Fracture after Discontinuation of Bisphosphonate Therapy
por: Gu, Kristine, et al.
Publicado: (2019)

SAT-534 How Has Bisphosphonate Prescribing Changed in the Past Decade for Primary Fracture?
por: Yang, Betsy, et al.
Publicado: (2019)

ODP080 Bisphosphonate treatment for osteoporosis in children with Gorham-Stout syndrome: a case report
por: Ahn, Moon Bae, et al.
Publicado: (2022)

SAT259 A Rare Case Of Bisphosphonate Refractory Hypercalcemia; Cancer Masquerading As Hidradenitis Suppurativa
por: Robles, Lydia A, et al.
Publicado: (2023)

OR13-03 Understanding Why Older People with Low Trauma Fractures Die Prematurely
por: Tran, Thach, et al.
Publicado: (2020)

OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019)

OR07-03 Continuous Subcutaneous Delivery of RhPTH(1-84) by Pump in Adults with Hypoparathyroidism
por: Bove-Fenderson, Erin, et al.
Publicado: (2020)

THU427 The Benefits Of Oral Bisphosphonates For Elderly Patients With A History Of Long Term Aromatase Inhibitor Use
por: Dominguez, Lorena D, et al.
Publicado: (2023)

Single Dose of Denosumab Effective for Management of Bisphosphonate-Refractory Hypercalcemia of Malignancy Related to Non-Small Cell Lung Cancer
por: Dinh, Kathryn, et al.
Publicado: (2021)

ODP112 Post-infusion ECG Changes in Patients Receiving Intravenous Bisphosphonates: a Systematic Review and Meta-Analysis
por: Shoung, Alex, et al.
Publicado: (2022)

SAT-LB69 Severe Disabling Musculoskeletal Pain as a Side Effect of Bisphosphonates: A Case Report and Review of Literature
por: Bawal, Dionise Ysabelle Vellon, et al.
Publicado: (2020)

SUN-508 Intravenous Bisphosphonates Induced Renal Injury with Nephrotic Range Proteinuria in a Patient with Severe Hypercalcemia Secondary to Parathyroid Carcinoma
por: Gorantla, Yamuna, et al.
Publicado: (2019)

ODP081 Bisphosphonates: To Give or Not to Give, that is the Question – A case of prolonged hypercalcemia in a patient with severe rhabdomyolysis complicated by bilateral foot drop
por: Musurakis, Clio, et al.
Publicado: (2022)

OR03-05 Cinacalcet Acts As A Spatially Biased Allosteric Modulator To Enhance CaSR Signaling From Endosomal Membranes
por: Wyatt, Rachael, et al.
Publicado: (2023)

Factors Associated With Inadequate Response to Bisphosphonate Therapy in Patients With Osteoporosis in Real-Life Clinical Practice: a Single-Center Retrospective Analysis of 300 Patients
por: Valadares, Luciana Pinto, et al.
Publicado: (2021)

OR29-03 Social Isolation Stress Leads To Bone Loss In Adult Male, But Not Female, C57BL/6J Mice
por: Mountain, Rebecca, et al.
Publicado: (2023)

OR29-03 The Effects of Hormone Therapy on Premature Ovarian Failure Following Allogenic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
por: Ha, Jeonghoon, et al.
Publicado: (2020)

OR03-3 High Spermidine Level was Associated with Increased Risk of Osteoporotic Fracture: A 10-Year Prospective Longitudinal Study in a Community-Based Cohort
por: Kong, Sung Hye, et al.
Publicado: (2019)

OR03-6 Tibial and Radial Bone Structure as Assessed by HRpQCT May Explain Differences in Peripheral Skeletal Integrity and Fracture Risk Across the Weight Spectrum That Cannot Be Explained by Areal BMD Alone
por: Schorr, Melanie, et al.
Publicado: (2019)

OR23-03 Sustained Normalization Of Mineral Homeostasis In Autosomal Dominant Hypocalcemia Type 1: Results From A Phase 2 Study Over 18 Months Of Encaleret (CLTX-305) Treatment (NCT04581629)
por: Ilana Gafni, Rachel, et al.
Publicado: (2023)

SAT-533 Men with Hypogonadism and Osteoporosis Benefit from Long-Term Testosterone Therapy (TTh) with Testosterone Undecanoate Injections (TU) Regardless of Co-Medication with Bisphosphonates: 10-Year Data from a Controlled Registry Study in a Urological Setting
por: Haider, Ahmad, et al.
Publicado: (2019)

OR07-05 Is Urinary Calcium the Only Predictor of Nephrolithiasis in Patients with Asymptomatic Primary Hyperparathyroidism?
por: Saponaro, Federica, et al.
Publicado: (2020)

SAT-394 Concordant Parathyroid Imaging; Frequency and Predictors of Concordance and Its Impacts on Cure
por: Khine, Aye Aye, et al.
Publicado: (2020)

MON-397 Potential Relationship Between Hypothyroidism and Bone Loss at Dental Implants
por: Yerke, Lisa Marie, et al.
Publicado: (2020)

SUN-390 Computed Tomography Derived Skeletal Muscle Radiodensity Is Better Predictor of Muscle Power Than Skeletal Muscle Area in Community-Dwelling Older Adults
por: Choi, Heewon, et al.
Publicado: (2020)

Creation of an Evidence-Based Physical Therapy Program for Adults with XLH: Translational Application of an Interprofessional Clinical Study
por: Kanamalla, Karthik, et al.
Publicado: (2021)

SUN-356 Burosumab Resulted in Greater Clinical Improvements Compared with Higher-dose Conventional Therapy in Children with X-linked Hypophosphatemia (XLH)
por: Imel, Erik A, et al.
Publicado: (2020)

SUN-343 Prevalence and Incidence of Hypomagnesemia and Hypermagnesemia in Medical Settings
por: Catalano, Antonino, et al.
Publicado: (2020)

SUN-336 Obesity and Impaired Glucose Metabolism in Adult Patients with X-Linked Hypophosphatemia
por: Lecoq, Anne-Lise, et al.
Publicado: (2020)

SUN-529 Burden of Illness in Adults with Hypophosphatasia: Data From the Global Hypophosphatasia Patient Registry
por: Kishnani, Priya, et al.
Publicado: (2019)

SUN-344 Patients with Fibrodysplasia Ossificans Progressiva Have an Increased Prevalence of Cardiac Conduction Abnormalities
por: Kou, Samuel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m09a9rga7t7n6pdfll00ncv53c